India on Monday reported 45,149 new Covid-19 cases, taking the country’s overall tally to 79,09,960, while 480 fatalities pushed the death toll to 1,19,014, according to data from the Union Health Ministry. There are 6,53,717 active coronavirus cases at present and 71,37,229 people have recovered from the disease. Active coronavirus cases have remained below 7 lakh for four days in a row, the health ministry said.
The health ministry further said that India’s case fatality rate is 1.5 per cent at present, the lowest since March 22. Fourteen states/union territories have a case fatality ratio of less than 1 per cent.
Maharashtra Deputy Chief Minister Ajit Pawar Monday said he has tested positive for Covid-19 and is admitted to a hospital in Mumbai. In a message, Pawar said his condition is fine and added, “I have tested positive for COVID-19. My health condition is fine. As a precautionary measure I have admitted self to Breach Candy Hospital on the advice of doctors.”
Meanwhile, the third phase of human trials of the indigenous Covid-19 vaccine Covaxin will begin at a private hospital in Bhubaneswar soon, PTI quoted an official as saying. Principal Investigator in the Covaxin human trial and Professor in the department of Community Medicine at the Institute of Medical Science and SUM Hospital said on Sunday. IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.
The indigenous vaccine being developed by ICMR and Bharat Biotech has received the approval of the Central Drugs Standard Control Organisation (CDSCO) for initiating the third phase trial.